IBRN ETF

IBRN ETF
$29.96
See how much of IBRN you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

US is IBRN's largest country exposure at 65.7% of the fund as of Oct 1, 2026. IBRN is iShares Neuroscience and Healthcare ETF.

Top Countries

#CountryRegionAllocation
1US
Global
65.72%
2Netherlands
Europe
4.27%
3Ireland
Europe
4.13%
4Canada
North America
3.83%
5South Korea
Asia-Pacific
3.29%
6Sweden
Europe
3.06%
7Denmark
Europe
2.59%
8United States
North America
2.55%
9Australia
Asia-Pacific
2.29%
10Japan
Asia-Pacific
2.06%
11Switzerland
Europe
1.90%
12India
Asia Pacific
1.30%
13China
Asia-Pacific
1.24%
14France
Europe
0.92%
15Hong Kong
Asia-Pacific
0.55%
16Italy
Europe
0.26%

IBRN ETF Geographic Allocation

IBRN geographic allocation spans US (65.7%), Netherlands (4.3%), Ireland (4.1%), Canada (3.8%), South Korea (3.3%). The fund covers 5 regions.

IBRN country exposure helps investors assess international diversification and geopolitical risk. IBRN sectors alongside geography give a fuller picture of portfolio allocation.

IBRN ETF Geographic Exposure

Market Development Overview

Developed Markets13 countries
31.7%
Emerging Markets3 countries
68.3%

Regional Allocation

Global
65.7%
45 holdings
Europe
17.1%
9 holdings
Asia-Pacific
9.4%
9 holdings
North America
6.4%
8 holdings
Asia Pacific
1.3%
1 holding

Country Breakdown (Top 20)

CountryRegionStatusAllocation
USGlobalEmerging
65.72%
NetherlandsEuropeDeveloped
4.27%
IrelandEuropeDeveloped
4.13%
CanadaNorth AmericaDeveloped
3.83%
South KoreaAsia-PacificDeveloped
3.29%
SwedenEuropeDeveloped
3.06%
DenmarkEuropeDeveloped
2.59%
United StatesNorth AmericaDeveloped
2.55%
AustraliaAsia-PacificDeveloped
2.29%
JapanAsia-PacificDeveloped
2.06%
SwitzerlandEuropeDeveloped
1.90%
IndiaAsia PacificEmerging
1.30%
ChinaAsia-PacificEmerging
1.24%
FranceEuropeDeveloped
0.92%
Hong KongAsia-PacificDeveloped
0.55%
ItalyEuropeDeveloped
0.26%